Similarly, low expression of MYH10 protein levels suggested shorten OS (p = 0.034, HR = 1.84; Figure 2I) and DFS (p = 0.017, HR = 1.86; Figure 2I) in HCC patients from the VALI cohort. Here, MYH10 is linked to hepatocellular carcinoma.